Cargando…

Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis

Background. TNF-α inhibitors have shown to be effective in reducing disease activity and improving the quality of life. Due to the high costs associated with acquisition of this treatment, this study was undertaken to evaluate the ICER of TNF-α antagonists (etanercept, adalimumab, and infliximab) in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Said, Cynthia, Coleiro, Bernard, Zarb Adami, Maurice, Azzopardi, Lilian M., Serracino Inglott, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845242/ https://www.ncbi.nlm.nih.gov/pubmed/24324915 http://dx.doi.org/10.1155/2013/581409

Ejemplares similares

Predictors of post-caesarean section pain and analgesic consumption
por: Buhagiar, Luana, et al.
Publicado: (2011)

Pre-operative pain sensitivity: A prediction of post-operative outcome in the obstetric population
por: Buhagiar, Luana Mifsud, et al.
Publicado: (2013)

Clinical pharmacist implementation of a medication assessment tool for long-term management of atrial fibrillation in older persons
por: Gauci, Marise, et al.
Publicado: (2019)

Assessing appropriateness of drug therapy in older persons: Development and application of a medication assessment tool for long-term management of atrial fibrillation
por: Gauci, Marise, et al.
Publicado: (2017)

Aggrecan Turnover in Women with Rheumatoid Arthritis Treated with TNF-α Inhibitors
por: Szeremeta, Anna, et al.
Publicado: (2020)

Influence of Insulin Resistance and TNF-α on the Inflammatory Process, Oxidative Stress, and Disease Activity in Patients with Rheumatoid Arthritis
por: Costa, Neide Tomimura, et al.
Publicado: (2016)

Exploring the Inflammatory Metabolomic Profile to Predict Response to TNF-α Inhibitors in Rheumatoid Arthritis
por: Cuppen, Bart V. J., et al.
Publicado: (2016)

ADAM17 Genetic Variants and the Response of TNF-α Inhibitor in Rheumatoid Arthritis Patients
por: Kim, Hyun Jeong, et al.
Publicado: (2020)

TNF-α and TNF-β Gene Polymorphism in Saudi Rheumatoid Arthritis Patients
por: Al-Rayes, Hannan, et al.
Publicado: (2011)

Predictors of response to TNF inhibitors in rheumatoid arthritis: an individual patient data pooled analysis of randomised controlled trials
por: Law-Wan, Johan, et al.
Publicado: (2021)

Randomised controlled trial examining the effect of exercise in people with rheumatoid arthritis taking anti-TNFα therapy medication
por: Reid, Angela, et al.
Publicado: (2011)

Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
por: Listing, Joachim, et al.
Publicado: (2015)

Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors
por: Jura-Półtorak, Agnieszka, et al.
Publicado: (2021)

Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis
por: Corrado, Addolorata, et al.
Publicado: (2017)

Metabolic Effects of Anti-TNF-α Treatment in Rheumatoid Arthritis
por: Macáková, Kristína, et al.
Publicado: (2023)

Fever of unknown origin: a challenging case
por: Vella, Sarah, et al.
Publicado: (2018)

Ankylosing Spondylitis and Rheumatoid Arthritis: Serum Levels of TNF-α and Its Soluble Receptors during the Course of Therapy with Etanercept and Infliximab
por: Schulz, Martin, et al.
Publicado: (2014)

The 'Switch’ study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug
por: Navarro Coy, Nuria C, et al.
Publicado: (2014)

Numerical simulations of patient-specific models with multiple plaques in human peripheral artery: a fluid-structure interaction analysis
por: Wang, Danyang, et al.
Publicado: (2020)

Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?
por: Ramiro, Sofia, et al.
Publicado: (2015)

Epstein–Barr virus load follow up in rheumatoid arthritis patients treated with TNF-α inhibitors
por: Balandraud, N, et al.
Publicado: (2004)

The Risk of Adverse Effects of TNF-α Inhibitors in Patients With Rheumatoid Arthritis: A Network Meta-Analysis
por: He, Bei, et al.
Publicado: (2022)

Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
por: Zamora-Atenza, Carlos, et al.
Publicado: (2014)

Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis
por: Lim, Heejin, et al.
Publicado: (2018)

The role of TNF-α in rheumatoid arthritis: a focus on regulatory T cells
por: Farrugia, Mark, et al.
Publicado: (2016)

Dose REduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study
por: den Broeder, Alfons A, et al.
Publicado: (2013)

The Effect of TNF-α on CHD and the Relationship between TNF-α Antagonist and CHD in Rheumatoid Arthritis: A Systematic Review
por: Qian, Yezhou, et al.
Publicado: (2022)

Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis
por: Huoponen, Saara, et al.
Publicado: (2019)

Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis
por: Cho, Soo-Kyung, et al.
Publicado: (2016)

Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis
por: Lopez-Rodriguez, Rosario, et al.
Publicado: (2018)

TNFα modulates protein degradation pathways in rheumatoid arthritis synovial fibroblasts
por: Connor, Alison M, et al.
Publicado: (2012)

Salivary TNFα levels in groups of subjects with rheumatoid arthritis and chronic periodontitis
por: Gamel, Ehsan B., et al.
Publicado: (2017)

The Cytokine Network in Rheumatoid Arthritis: Definition of TNFα as a Therapeutic Target
por: Feldmann, Marc
Publicado: (1996)

Changing paradigms in bioequivalence trials submitted to the EMA for evaluation – A clinical and regulatory perspective
por: Refalo, Nathaniel, et al.
Publicado: (2017)

Popliteal artery pseudoaneurysm treated with covered stent placement and thrombolysis: a case report
por: Katsogridakis, Emmanuel, et al.
Publicado: (2015)

Dysregulation of RasGRP1 in rheumatoid arthritis and modulation of RasGRP3 as a biomarker of TNFα inhibitors
por: Golinski, Marie-Laure, et al.
Publicado: (2015)

Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF(+) T Lymphocytes
por: Bystrom, Jonas, et al.
Publicado: (2017)

Identification of Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor in Rheumatoid Arthritis Using Network Pharmacology and Molecular Docking
por: Bai, Liang Liang, et al.
Publicado: (2021)

Use of TNF Inhibitors in Rheumatoid Arthritis and Implications for the Periodontal Status: For the Benefit of Both?
por: Zamri, Fatima, et al.
Publicado: (2020)

What Is the Clinical Relevance of TNF Inhibitor Immunogenicity in the Management of Patients With Rheumatoid Arthritis?
por: Mehta, Puja, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lrca1srvhrftoqka5ikirp7dog